Eh, most of their profits being unexplained other kills the vibe.
Man I wish I could also have 7.3 fucking billions of unexplained money dropping out of nowhere.
“Other” seems to be profitable
$7.3B in “other”
Wtf is that
Did they classify sales to Diddy in the $7.3B of “Other”?
“other” is doing most of the lifting here
Putting my tinfoil hat on but it is become clearer by the day that big pharma has a big interest in keeping some matters unsolvable/uncurable to keep profiting big
Not an expert, but apparently much of the profits in the “Other” category are basically any non-sales related gain on assets, including:
-Sale/Divestment of assets and equipment
-R&D contracts (companies using J&J teams for their R&D)
-Data related revenues
-Licensing Revenues and gains from sale of IP
In case anybody was wondering what makes up “other” profits!
This is Lucy Ricardo accounting.
For everyone wondering at the “other”, it is more accurate to call it “Tort Reversals and Litigation Shit”.
AKA they earmarked court damages related to a bankruptcy (already showed up as losses in a previous earnings report), so those are showing back up as “other” income for now while they litigate.
What do you mean 7.3 BILLION IN “other profits”
What I like i the inflated R&D at $3.2B; even halving the profit fully covers R&D, even the fake R&D. So much for the lie that they need to recoup massive R&D expenses.
Ok so how do I get started in the “Other” industry?
Nice, now they can pay damages for all the people they exposed to asbestos with their talc.
Steps for success:
– Make multi-national corporation
– Cold showers at 5am
– Lose money
– *Other*
– Profit
Tables on page 18 show J&J’s reconciliation between GAAP earnings and their own non-GAAP earnings, and “Other (Income) / Expense” shows $6.966B in “Litigation related” expenses not included in their $7.3B in GAAP earnings.
![[OC] How Johnson&Johnson made it’s latest Billions](https://www.europesays.com/wp-content/uploads/2025/04/5gb1hmkpa7ve1-1920x1024.png)
28 comments
Source: [Johnson&Johnson investor relations](https://s203.q4cdn.com/636242992/files/doc_financials/2025/q1/1Q25-Earnings-Press-Release-Final-Draft-4-14-with-Attachments.pdf)
Tool: [SankeyArt](http://sankeyart.com) Sankey diagram maker
Eh, most of their profits being unexplained other kills the vibe.
Man I wish I could also have 7.3 fucking billions of unexplained money dropping out of nowhere.
“Other” seems to be profitable
$7.3B in “other”
Wtf is that
Did they classify sales to Diddy in the $7.3B of “Other”?
“other” is doing most of the lifting here
Putting my tinfoil hat on but it is become clearer by the day that big pharma has a big interest in keeping some matters unsolvable/uncurable to keep profiting big
Not an expert, but apparently much of the profits in the “Other” category are basically any non-sales related gain on assets, including:
-Sale/Divestment of assets and equipment
-R&D contracts (companies using J&J teams for their R&D)
-Data related revenues
-Licensing Revenues and gains from sale of IP
In case anybody was wondering what makes up “other” profits!
This is Lucy Ricardo accounting.
For everyone wondering at the “other”, it is more accurate to call it “Tort Reversals and Litigation Shit”.
https://www.jnj.com/media-center/press-releases/johnson-johnson-to-return-to-tort-system-to-defeat-meritless-talc-claims
AKA they earmarked court damages related to a bankruptcy (already showed up as losses in a previous earnings report), so those are showing back up as “other” income for now while they litigate.
What do you mean 7.3 BILLION IN “other profits”
What I like i the inflated R&D at $3.2B; even halving the profit fully covers R&D, even the fake R&D. So much for the lie that they need to recoup massive R&D expenses.
Ok so how do I get started in the “Other” industry?
Nice, now they can pay damages for all the people they exposed to asbestos with their talc.
Steps for success:
– Make multi-national corporation
– Cold showers at 5am
– Lose money
– *Other*
– Profit
$7.3B in “Other” income in the sankey comes from “Other (income) expense, net” on pages 9 and 18 of the [Johnson&Johnson investor relations](https://s203.q4cdn.com/636242992/files/doc_financials/2025/q1/1Q25-Earnings-Press-Release-Final-Draft-4-14-with-Attachments.pdf) document.
Tables on page 18 show J&J’s reconciliation between GAAP earnings and their own non-GAAP earnings, and “Other (Income) / Expense” shows $6.966B in “Litigation related” expenses not included in their $7.3B in GAAP earnings.
Maybe this number has to do with the talc lawsuits settlement that just got rejected a few days ago. [https://www.sokolovelaw.com/blog/johnson-johnson-bankruptcy-update-talc-settlement-rejected/](https://www.sokolovelaw.com/blog/johnson-johnson-bankruptcy-update-talc-settlement-rejected/)
[edit: added the ‘B’ to $6.966. Without that, this comment would have been a net loss.]
Maybe it’s a typo, and those 7+ billions come from products for OTTERS.
Very interesting. What software do you use to make these charts?
66.36% of their net profit is “Other.” Sure seems right to me.
“Other” for >7 billion in profits? Seems legit…
I would like a little bit of Other in my life
I like how operating profit and other dont even add up to net profit. Lol
That “other” is doing some heavy lifting…
Really surprised that their tax is 24% of their profits. This is a positive sign as their contributions to society.
They are clearly not bribing politicians enough like other companies /s
I still don’t know how to decipher these types of graphs.
There’s a bracket missing called lawsuits
And yet they still milk tuberculosis drugs that could save hundreds of thousands of lives
Comments are closed.